Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Eureka Therapeutics Inc.
Description mAb targeting extracellular tumor antigens
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation
PartnerFive Prime Therapeutics Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today